Free Trial

AIM ImmunoTech (AIM) Institutional Ownership

AIM ImmunoTech logo
$0.25 -0.01 (-1.94%)
Closing price 05/15/2026 04:10 PM Eastern
Extended Trading
$0.26 +0.01 (+2.37%)
As of 05/15/2026 07:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for AIM ImmunoTech (NYSEAMERICAN:AIM)

Current
Institutional Ownership
Percentage
12.02%
Number of
Institutional Buyers
(last 12 months)
3
Total
Institutional Inflows
(last 12 months)
$281.47K
Number of
Institutional Sellers
(last 12 months)
0
Get AIM Insider Trade Alerts

Want to know when executives and insiders are buying or selling AIM ImmunoTech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

AIM Institutional Buying and Selling by Quarter

AIM ImmunoTech Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/12/2026 DRW Securities LLC69,545$79K0.0%+60.6%2.120%
11/14/2025 Sabby Management LLC28,855$79K0.1%N/A1.065%
9/26/2025 Corient Private Wealth LLC10,001$87K0.0%N/A0.369%
8/15/2025 Corient Private Wealth LLC10,001$87K0.0%N/A1.309%
2/17/2025Citadel Advisors LLC358,987$71K0.0%-21.6%0.563%
8/15/2024Armistice Capital LLC4,078,000$1.52M0.0%N/A7.919%


AIM Institutional Ownership - Frequently Asked Questions

During the previous two years, the following institutional investors and hedge funds held shares of AIM ImmunoTech shares: Armistice Capital LLC ($1.52M), Corient Private Wealth LLC ($87K), DRW Securities LLC ($79K), and Sabby Management LLC ($79K), Citadel Advisors LLC ($71K).Learn more on AIM ImmunoTech's institutional investors.

12.02% of AIM ImmunoTech's stock is owned by institutional investors. Learn more on AIM's institutional investor holdings.

The following institutional investors have purchased AIM ImmunoTech's stock in the last 24 months: Armistice Capital LLC ($4.08M), Sabby Management LLC ($28.86K), DRW Securities LLC ($26.25K), and Corient Private Wealth LLC ($20.00K).

Institutional investors have bought a total of 75,111 shares in the last 24 months. This purchase volume represents approximately $281.47K in transactions.



This page (NYSEAMERICAN:AIM) was last updated on 5/17/2026 by MarketBeat.com Staff.
From Our Partners